BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3319 related articles for article (PubMed ID: 19797974)

  • 1. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.
    Hee L; Mussap CJ; Yang L; Dignan R; Kadappu KK; Juergens CP; Thomas L; French JK
    Am J Cardiol; 2012 Sep; 110(5):643-8. PubMed ID: 22632829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis.
    White AJ; Kedia G; Mirocha JM; Lee MS; Forrester JS; Morales WC; Dohad S; Kar S; Czer LS; Fontana GP; Trento A; Shah PK; Makkar RR
    JACC Cardiovasc Interv; 2008 Jun; 1(3):236-45. PubMed ID: 19463306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials.
    Onuma Y; Wykrzykowska JJ; Garg S; Vranckx P; Serruys PW;
    JACC Cardiovasc Interv; 2011 Mar; 4(3):317-23. PubMed ID: 21435610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy).
    Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E
    Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved long-term survival for diabetic patients with surgical versus interventional revascularization.
    Kurlansky P; Herbert M; Prince S; Mack MJ
    Ann Thorac Surg; 2015 Apr; 99(4):1298-305. PubMed ID: 25686668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes mellitus on the treatment effect of percutaneous or surgical revascularization for patients with unprotected left main coronary artery disease: a subgroup analysis of the MAIN-COMPARE study.
    Kim WJ; Park DW; Yun SC; Lee JY; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2009 Oct; 2(10):956-63. PubMed ID: 19850255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
    Aronson D; Edelman ER
    Rev Endocr Metab Disord; 2010 Mar; 11(1):75-86. PubMed ID: 20221852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve months clinical outcome of drug-eluting stents implantation or coronary artery bypass surgery for the treatment of diabetic patients with multivessel disease.
    Qiao Y; Ma C; Nie S; Liu X; Kang J; Lv Q; Du X; Hu R; Zhang Y; Jia C; Liu X; Dong J; Chen F; Zhou Y; Lv S; Huang F; Gu C; Wu X
    Clin Cardiol; 2009 Aug; 32(8):E24-30. PubMed ID: 19455692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
    De Luca G; Schaffer A; Verdoia M; Suryapranata H
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 166.